Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
M3 Inc (2413 JP)
Watchlist
162
Analysis
Health Care
•
Japan
M3, Inc. supplies medical information services for doctors through the Internet. The Company also supports marketing of pharmaceutical companies and medical equipment manufacturers.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
27 Jan 2019 19:49
Japan: Moving Average Outliers - Tech[nical] Rebound
- MARKET COMPOSITE - SLOW & STEADY RECOVERY - From December 25th's lows of 8% by number and 11% by value, the percentages of Japanese stocks...
Campbell Gunn
Follow
720 Views
Share
bearish
•
Quantitative Analysis
•
13 Nov 2018 15:56
Japan: Relative Price Score Update - Overbought and Oversold Companies
RELATIVE PRICE SCORE - The Relative Price Score (RPS) measures stock price performance relative to TOPIX and is calculated by comparing the current...
Campbell Gunn
Follow
637 Views
Share
bullish
•
Quantitative Analysis
•
11 Nov 2018 18:54
Japan: Moving Average Outliers - Results Driven
MOVING AVERAGE OUTLIERS - Our moving average outlier indicator uses a weighted sum of the share price relative to the 5-day, 20-day, 60-day, 120...
Campbell Gunn
Follow
565 Views
Share
bullish
•
Sony Corp
•
05 Mar 2018 05:03
Sony (6758 JP) - Spotify Stake Adds Another US$1.14bil to Sum of the Parts
While there was no surprise in the announcement that music streaming site Spotify is to go public – the firm has been taking a series of measures...
Pelham Smithers Associates
324 Views
Share
bullish
•
Sony Corp
•
02 Aug 2017 11:37
Sony (6758) How Good, Really, Was Its "Blow-Out" June Quarter?
Sometime around 2003, Sony started generating "exceptionals" and it hasn't stopped since. Whether it is writedowns on business closures, write-offs...
Pelham Smithers Associates
355 Views
Share
First
Previous
28
29
30
31
32
33
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x